Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.24M Buy
42,705
+5,559
+15% +$294K 0.01% 396
2026
Q1
$2.05M Buy
37,146
+25,073
+208% +$1.36M 0.01% 389
2025
Q4
$592K Sell
12,073
-1,315
-10% -$61.3K ﹤0.01% 532
2025
Q3
$578K Sell
13,388
-651
-5% -$25.4K ﹤0.01% 522
2025
Q2
$539K Buy
14,039
+3,927
+39% +$150K ﹤0.01% 521
2025
Q1
$392K Sell
10,112
-190
-2% -$6.96K ﹤0.01% 563
2024
Q4
$348K Sell
10,302
-288
-3% -$10.4K ﹤0.01% 582
2024
Q3
$433K Buy
10,590
+402
+4% +$16.4K ﹤0.01% 548
2024
Q2
$392K Sell
10,188
-150
-1% -$6.31K ﹤0.01% 541
2024
Q1
$443K Sell
10,338
-1,267
-11% -$52.3K ﹤0.01% 513
2023
Q4
$430K Buy
11,605
+5,772
+99% +$207K ﹤0.01% 506
2023
Q3
$211K Buy
5,833
+857
+17% +$30.4K ﹤0.01% 634
2023
Q2
$177K Buy
4,976
+78
+2% +$2.8K ﹤0.01% 692
2023
Q1
$174K Sell
4,898
-2,046
-29% -$71.6K ﹤0.01% 658
2022
Q4
$244K Sell
6,944
-227
-3% -$7.56K ﹤0.01% 590
2022
Q3
$211K Sell
7,171
-1,875
-21% -$71.1K ﹤0.01% 603
2022
Q2
$492K Buy
9,046
+607
+7% +$33.5K 0.01% 481
2022
Q1
$459K Sell
8,439
-355
-4% -$19.3K ﹤0.01% 501
2021
Q4
$485K Buy
8,794
+2,015
+30% +$105K ﹤0.01% 490
2021
Q3
$324K Sell
6,779
-1,068
-14% -$53.6K ﹤0.01% 532
2021
Q2
$391K Buy
7,847
+652
+9% +$31.3K ﹤0.01% 509
2021
Q1
$321K Hold
7,195
﹤0.01% 451
2020
Q4
$330K Sell
7,195
-382
-5% -$17.5K ﹤0.01% 432
2020
Q3
$357K Buy
7,577
+946
+14% +$47.4K 0.01% 412
2020
Q2
$338K Sell
6,631
-1,939
-23% -$99.5K 0.01% 414
2020
Q1
$406K Buy
8,570
+353
+4% +$18.8K 0.01% 385
2019
Q4
$482K Buy
8,217
+1,803
+28% +$100K 0.01% 397
2019
Q3
$343K Buy
6,414
+92
+1% +$4.73K 0.01% 434
2019
Q2
$316K Sell
6,322
-1,356
-18% -$68K 0.01% 451
2019
Q1
$401K Sell
7,678
-1,148
-13% -$57.4K 0.01% 412
2018
Q4
$421K Sell
8,826
-6,289
-42% -$310K 0.01% 412
2018
Q3
$759K Buy
15,115
+244
+2% +$12.4K 0.01% 381
2018
Q2
$749K Sell
14,871
-1,831
-11% -$92.2K 0.01% 373
2018
Q1
$815K Sell
16,702
-1,684
-9% -$78.4K 0.01% 372
2017
Q4
$815K Sell
18,386
-1,520
-8% -$70.2K 0.01% 379
2017
Q3
$1.01M Sell
19,906
-560
-3% -$28.4K 0.02% 358
2017
Q2
$1.1M Sell
20,466
-656
-3% -$35K 0.02% 346
2017
Q1
$1.11M Buy
21,122
+1,702
+9% +$86.3K 0.02% 351
2016
Q4
$934K Sell
19,420
-4,366
-18% -$216K 0.02% 371
2016
Q3
$1.28M Buy
23,786
+3,217
+16% +$176K 0.02% 325
2016
Q2
$1.11M Sell
20,569
-12,784
-38% -$673K 0.03% 291
2016
Q1
$1.92M Buy
33,353
+11,612
+53% +$578K 0.05% 251
2015
Q4
$1.1M Sell
21,741
-1,819
-8% -$92.7K 0.03% 310
2015
Q3
$1.13M Sell
23,560
-2,762
-10% -$144K 0.03% 310
2015
Q2
$1.37M Sell
26,322
-7,031
-21% -$396K 0.03% 290
2015
Q1
$1.92M Sell
33,353
-269
-0.8% -$15.4K 0.05% 252
2014
Q4
$1.8M Sell
33,622
-40,106
-54% -$2.24M 0.04% 258
2014
Q3
$4.24M Buy
73,728
+28,576
+63% +$1.75M 0.09% 234
2014
Q2
$3.02M Sell
45,152
-94,598
-68% -$6.4M 0.06% 326
2014
Q1
$9.33M Buy
139,750
+100,672
+258% +$6.81M 0.18% 139
2013
Q4
$2.61M Sell
39,078
-364
-0.9% -$23.6K 0.07% 218
2013
Q3
$2.47M Sell
39,442
-392
-1% -$25.2K 0.07% 208
2013
Q2
$2.49M Buy
+39,834
New +$2.53M 0.08% 199

Other funds holding GSK

Huntington National Bank's GSK Position: Q2 2026 in Review

Huntington National Bank increased its GSK (GSK) stake by 15% in Q2 2026, buying an estimated $294K and bringing the position to 42,705 shares worth $2.24M. The position accounts for 0.01% of the portfolio, ranked #396.

Huntington National Bank first reported a position in GSK in Q2 2013 and has held it in 53 quarters since. The position peaked at $9.33M in Q1 2014. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Huntington National Bank held 42,705 shares of GSK worth $2.24M as of Q2 2026.
  • Huntington National Bank bought 5,559 GSK shares in Q2 2026, an estimated $294K.
  • GSK made up 0.01% of Huntington National Bank's portfolio in Q2 2026, its #396 holding.
  • Huntington National Bank first reported a position in GSK in Q2 2013 and has held it in 53 quarters since.
  • Huntington National Bank's GSK position peaked at $9.33M in Q1 2014.
  • 1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Huntington National Bank's 13F filing for Q2 2026, filed 13 Aug 2026.